Contraceptive Considerations for TNGD AFAB Patients

Released: 09/26/2024

This job aid assists the clinical provider with contraceptive considerations for transgender, nonbinary, and gender diverse (TNGD) patients assigned female at birth (AFAB). Special considerations are given for contraception for people on concurrent testosterone use, potential side effects, and menstrual suppression. Contraceptive methods are listed according to menstrual suppression, possibility of spotting/bleeding, cramping, breast tissue tenderness, and self-disclosure.

University of Missouri – Kansas City
School of Nursing & Health Sciences
2464 Charlotte St.
Kansas City, MO 64108
OUR PARTNER
oash OPA logo blue
Supported by the Department of Health and Human Services / Office of Population Affairs / Office of Family Planning Grant #1 FPTPA006031-01-00.

CTC-SRH is supported by the office of Population Affairs of the U.S. Department of Health and Human Services. The information presented does not necessarily represent the views of OPA, OASH, or DHHS
reproductivehealthservices.gov
COPYRIGHT © 2024 THE CLINICAL TRAINING CENTER FOR SEXUAL & REPRODUCTIVE HEALTH
Read our privacy policy
magnifiercrosschevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram